Last reviewed · How we verify
NCT06372691
How Do We Ultrasound-Guided Popliteal Approach Sciatic Nerve Block?
NA trial testing Subparaneural Injection (Grup S), Block in Adult in 92 participants. Completed in 1 April 2025.
1 February 2025
Quick facts
| Lead sponsor | Ankara City Hospital Bilkent |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | other |
| Enrollment | 92 |
| Start date | 1 May 2024 |
| Primary completion | 1 February 2025 |
| Estimated completion | 1 April 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Subparaneural Injection (Grup S), Block
- Interneural Injection (Grup I), Block
Conditions studied
- Adult — all drugs for Adult →
- Regional Anesthesia Morbidity — all drugs for Regional Anesthesia Morbidity →
- Anesthesia Injection Site — all drugs for Anesthesia Injection Site →
Sponsor
Ankara City Hospital Bilkent
Who can join
18 and older, any sex, with Adult or Regional Anesthesia Morbidity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this prospective, randomized, observer-blind study to compare subparaneural approach injection with interneural approach injection in popliteal sciatic nerve blocks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06372691
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adult
Currently open trials in the same condition.
- NCT07354607 — Effect of Transcutaneous Electrical Stimulation on Peripheral Blood Flow · NA · recruiting
- NCT07163728 — Leptin: A Marker for AML Chemo-Sensitivity · recruiting
- NCT07035171 — CABGpreHAB - a Feasibility Study Protocol · NA · recruiting
- NCT07018518 — PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma · Phase 1 · recruiting
- NCT06883149 — PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor · Phase 1 · recruiting
Other Ankara City Hospital Bilkent trials
Trials by the same sponsor.
- NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
- NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
- NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
- NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
- NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06372691 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
- Last refreshed: 20 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06372691.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing